Neurocrine Biosciences, Inc.
USD179.05
+6.05 (+3.50%)
CEO
Kyle W. Gano
IPO Date
1996-05-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$174.77
Prev. Close
$173.00
Day Low
$174.50
Day High
$179.05
52W Low
$122.14
52W High
$181.18
Market Cap
$18.00B
Volume
1.24M
| 4,367 |
| $181.02 |
| 13 Jul 2026 | Delaet Ingrid | Chief Regulatory Officer | M-Exempt | Disposed | 4,367 | $106.02 |
| 13 Jul 2026 | Lippoldt Darin | Chief Legal Officer | M-Exempt | Acquired | 10,000 | $81.49 |
| 13 Jul 2026 | Lippoldt Darin | Chief Legal Officer | S-Sale | Disposed | 10,000 | $179.60 |
| 13 Jul 2026 | Lippoldt Darin | Chief Legal Officer | M-Exempt | Disposed | 10,000 | $81.49 |
| 9 Jul 2026 | Delaet Ingrid | Chief Regulatory Officer | M-Exempt | Acquired | 3,401 | $103.52 |
| 9 Jul 2026 | Delaet Ingrid | Chief Regulatory Officer | S-Sale | Disposed | 3,401 | $178.57 |
| 9 Jul 2026 | Delaet Ingrid | Chief Regulatory Officer | M-Exempt | Acquired | 2,737 | $103.52 |
| 9 Jul 2026 | Delaet Ingrid | Chief Regulatory Officer | S-Sale | Disposed | 2,737 | $178.54 |
| 18 Sept 2024 | Michael McCaul | Michael McCaul | Sale | $1,001 - $15,000 |
| 17 Nov 2023 | Michael McCaul | Michael McCaul | Sale | $15,001 - $50,000 |
| 17 Nov 2023 | Michael McCaul | Michael McCaul | Sale | $50,001 - $100,000 |
| 20 Sept 2023 | Michael McCaul | Michael McCaul | Purchase | $50,001 - $100,000 |
| 20 Sept 2023 | Michael McCaul | Michael McCaul | Purchase | $15,001 - $50,000 |
| 22 Jun 2023 | Michael McCaul | Michael McCaul | Sale | $15,001 - $50,000 |
| 8 Mar 2023 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |